Employer record no. 17619
Kymera Therapeutics, Inc.
US DOL LCA disclosure data, FY2021 to FY2026
Total LCA filings
21
Certified
21
Denied
0
FY2025 filings
5
Filings by fiscal year
* partial fiscal year; quarters still being published by DOL
Peer rank
#1,400 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2021 | 3 | 3 | 0 | $90,327 | $90,327 |
| FY2022 | 3 | 3 | 0 | $98,333 | $82,451 |
| FY2023 | 4 | 4 | 0 | $117,500 | $87,225 |
| FY2024 | 2 | 2 | 0 | $125,000 | $107,287 |
| FY2025 | 5 | 5 | 0 | $157,000 | $106,717 |
| FY2026 * | 4 | 4 | 0 | $187,179 | $146,578 |
What they file for
- associate director, translational medicine$180,0002
- associate scientist, platform biology$102,5002
- associate director, bioanalytical$185,0001
- associate scientist, cellular pharmacology$113,0001
- associate scientist, computational biology$85,0001
- associate scientist, discovery biology$125,7151
- director, late stage formulations development$230,0001
- principal scientist, biological sciences$160,0001
Where
- watertown, ma21
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Kymera Therapeutics, Inc. and any other employer they watch.
Certification rate 100.0%How these numbers are computed